ARCHIVES

Phase III Avastin Trial Fails Primary Endpoints

This article is from The Cancer Letter archive.

Vol. 37 No. 2 | February 28, 2014

Download PDF Visit The Full Archive

Related Articles

Appeals Court Overturns FDA Approval Of Generic Paclitaxel, A Setback For Ivax.

November 9, 2001

Pharmacia Letter Announces Suspension Of Two Trials.

May 11, 2001

Army Hopes To Fund “Middle-Risk, high Payoff” Research With Breast Cancer money. Travis Says

February 19, 1993

Drugs Available To Investigators Centers to Monitor Them Are Listed

September 9, 1977

NCI to Implement More Transparent Formula For Calculating Cancer Center Support Grants

June 11, 2014

Young Molecular Biologists Optimistic, Survey Finds

February 21, 1997